Viavi Solutions is trading 4.22% down now at $37.49 as investors continue reassessing its August 5 earnings reaction.
- The company beat fiscal fourth-quarter estimates and issued strong first-quarter guidance, but analysts flagged valuation, a higher diluted share count, and near-term cost concerns.
- Needham lowered its price target to $60 from $68, while UBS cut its target to $44 from $60.
- Broader markets are largely flat, offering limited support.